By Amanda Patton
Although multidisciplinary cancer care is synonymous with access to cutting-edge treatment options, including clinical trials, improving nationwide patient participation remains a challenge. Learn how this large independent oncology practice in northwest Arkansas grew its research program to offer patients access to phase I, II, and III trials in the communities where they live and work.
Members: Access the Full Issue (Requires Login) Non-Member Access
At a time of unprecedented change and uncertainty, the ACCC 47th Annual Meeting & Cancer Center Business Summit1414, March 1-5, will provide critical guidance on the hot-button issues impacting cancer care delivery. Discover strategies to implement telehealth and virtual care in a sustainable way that benefits patients, providers, and payers; optimize revenue cycle management and protect your bottom line during a time of financial hardship; improve health equity and patient access to cutting-edge treatments, like clinical trials; and prepare for reimbursement and policy changes. View agenda sessions and speakers2121, then reserve your seat33 today.
Created to better understand the needs of cancer programs and guide the agenda, the AMCCBS Advisory Board and Task Force44 comprise a group of industry experts and cancer care professionals from diverse backgrounds, locations, and organizations.
”The Task Force worked collaboratively over the past several months to prioritize issue areas most relevant to the current and ever-changing landscape in oncology. By identifying what is ‘top of mind’ to ACCC members, we are able to identify thought leaders to share their expertise with the wider oncology community.”
Director of Strategic Initiatives, Oncology Service Line, Mount Sinai Health System
AMCCBS Task Force Member
Access These Resources—and More—at ACCC-CANCER.ORG/COVID-19.